Research investigates how chirality and anions affect structures of silver complexes and polymers, suggesting implications for material design.
Chiral and racemic forms of a pyridyl ligand (R-L and rac-L, respectively), containing urea groups at their core and synthesised by the condensation of 3-aminopyridine and α-methylbenzylisocyante, were incorporated into silver complexes. The resulting species depend on the enantiopurity of the ligand alongside an influence from the counter-anion. The enantiopure ligand generated isomorphous, one-dimensional polymeric compounds [Ag(R-L)X] (where X = NO3, CF3SO3) or [Ag(R-L)]X (where X = BF4, PF6). The polymeric chains, connected by N and O coordination of the ligands, have outwards facing urea groups that form hydrogen bonds to the counter-anions, which play little role in determining the overall structure. Despite all syntheses containing an excess of Ag(I) salt, the racemic ligand formed only discrete complexes of [Ag(rac-L)2]+ in the presence of each of the above anions. Three of these complexes contain ligands of the same chirality (i.e., complexes with R,R and S,S ligand pairs within the centrosymmetric structures) with only the PF6-containing compound being different. The anions play a role in dictating the structure of hydrogen-bonded chains, although PF6− is unique with urea···urea interactions present between complexes. Overall, this system highlights the nuances associated with predicting the structure, and even speciation, of related chiral/achiral systems in addition to influences of counter-anions on structural motifs.
No takes yet. Share an insight, caveat, or question.
Sawant et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: